| Zugriffe | |
|---|---|
| Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109) | 56 |
| Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | |
|---|---|---|---|---|---|---|---|
| Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109) | 4 | 3 | 3 | 0 | 1 | 5 | 3 |
| Zugriffe | |
|---|---|
| 2020_Kurreck_etal.pdf | 38 |
